35+ clinical studies. Definitive science.
Our peer-reviewed, published scientific studies have expanded our NAD+ knowledge and validated our approach. Each clinical trial adds to the growing body of evidence supporting Niagen's efficacy. We pursue scientific excellence without compromise.
Backed by gold standard science, quality, and safety

Efficacy backed by peer-reviewed published research
Niagen® is supported by 35+ clinical studies demonstrating its safety and efficacy. These human studies form the foundation of our scientific evidence. Over 65% of registered ongoing or completed nicotinamide riboside trials use Niagen.²
Partnership with 200+ institutions: Our CERP program partners with top institutions like Mayo Clinic, National Institute on Aging, Harvard, and Cambridge.
Backed by independent research: Over 90% of Niagen studies are investigator-driven and third-party funded.
Partnership with 200+ institutions: Our CERP program partners with top institutions like Mayo Clinic, National Institute on Aging, Harvard, and Cambridge.
Backed by independent research: Over 90% of Niagen studies are investigator-driven and third-party funded.
View studies and publications